Accepted at: Oct, 07, 2026 11:52 p.m.
Author: ben.jamin92
Related Deck: 1675118865074
Accepted
Rationale for new note

New

Text
Text
What effect does short-acting bronchodilator therapy have on the rate of lung function decline or survival in COPD?<br><br>{{c1::None}}
Extra
Extra
<ul><li> There is no evidence of benefit for either</li><li>SABA is for short-term symptom relief</li></ul>
Extra (Synced)
Empty field
Extra (Synced)
Personal Notes
Empty field
Personal Notes
Missed Questions
Empty field
Missed Questions
eTG Complete
Empty field
eTG Complete
Talley & O'Connor
Empty field
Talley & O'Connor
Additional Resources
Empty field
Additional Resources
Additional Resources (Synced)
Empty field
Additional Resources (Synced)
Source
Source
<div><div>Stable chronic obstructive pulmonary disease (COPD) [amended 2025 Mar]. In: Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited; accessed 2026 Aug. <a href="https://www.tg.org.au/">www.tg.org.au</a><br> <div>National Guideline: LFA (Lung Foundation Australia). LFA COPD-X Guide. Accessed Aug 9, 2026</div></div></div>
One by one
Empty field
One by one
Tags
#Malleus_CM::#Resources_by_Rotation::Internal_Medicine::General_Medicine #Malleus_CM::#Question_Banks::eMedici::0-999::175 #Malleus_CM::#Resources_by_Rotation::General_Practice #Malleus_CM::#eTG_Complete::Respiratory::Chronic_obstructive_pulmonary_disease::Stable_chronic_obstructive_pulmonary_disease_(COPD) #Malleus_CM::#Guidelines::Australia::National::LFA_(Lung_Foundation_Australia)::LFA_COPD-X_Guide #Malleus_CM::#Resources_by_Rotation::Internal_Medicine::Respiratory_Medicine #Malleus_CM::#Subjects::Respiratory_Medicine::01_Parenchymal_Disease::01_Obstructive::COPD::10_Management #Malleus_CM::#Yield::Medium #Malleus_CM::#Subjects::Critical_Care::02_Breathing::COPD::10_Management